Pharmacies - Indonesia | Statista Market Forecast

The Pharmacies market in Indonesia is expected to achieve a revenue of US$14.41bn by 2024.
It is projected to exhibit a compound annual growth rate (CAGR 2024-2029) of 4.55%, leading to a market volume of US$17.99bn by 2029.
When compared on a global scale, United States is anticipated to generate the highest revenue of US$387.30bn in 2024.
In terms of per capita income, each individual in Indonesia is estimated to generate a revenue of US$51.49 in 2024.
Indonesia's pharmacy market is experiencing a surge in demand for traditional herbal remedies due to a growing preference for natural and holistic healthcare solutions.

Definition:
Pharmacies are physical or digital places where mainly pharmaceuticals and medical products are sold. Additionally, they also sell other items that are generally found in a pharmacy, such as food supplements, cosmetic products, and other health-related goods. A large proportion of pharmaceuticals are only available on prescription; the rest of the product range of pharmacies is sold over the counter (OTC). Besides selling products, pharmacies also advise customers, inform them about undesirable effects of the products, and detect possible interactions with other medicines.

Structure:
The Pharmacies market consists of two markets: Prescriptions Drugs and OTC Products. The Prescription Drugs market covers all products – mainly pharmaceuticals – that are only available on prescription. The OTC Products market comprises all products that are sold over the counter (OTC), including pharmaceuticals, medical devices, and other items that are generally found in a pharmacy.

Additional information:
The KPIs shown include revenue, revenue growth, average revenue per pharmacy, average revenue per capita, number of pharmacies, pharmacy density, users, and the online sales share for the OTC Products market. Revenues are generated through offline and online spending by (B2C) consumers and include VAT. B2B and B2G sales as well as other pharmaceutical sales through hospitals or retail stores, such as supermarkets, are not included.
For more information on the data displayed, use the info button next to the boxes.

Prescription pharmaceuticals
Prescription medical products
OTC pharmaceuticals
OTC medical products
Pharmacy-usual items

Services such as vaccinations
Sales through hospitals or retail stores

The Pharmacies market in Indonesia has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in the Pharmacies market in Indonesia have played a crucial role in driving its growth. Customers in Indonesia have shown a preference for easily accessible healthcare services, including pharmacies. This preference is driven by factors such as convenience, affordability, and the availability of a wide range of over-the-counter medications. Additionally, the increasing awareness of the importance of self-medication and preventive healthcare has also contributed to the growth of the Pharmacies market in Indonesia. Several trends have emerged in the Pharmacies market in Indonesia that have further fueled its development. One notable trend is the increasing adoption of digital technologies by pharmacies. Many pharmacies in Indonesia have embraced online platforms and mobile applications to enhance their services and reach a wider customer base. This trend has not only improved convenience for customers but has also allowed pharmacies to offer personalized services and recommendations based on customer data. Another trend in the Pharmacies market in Indonesia is the growing focus on providing holistic healthcare solutions. Pharmacies are expanding their product offerings beyond traditional medications to include a range of wellness and beauty products. This trend is driven by the rising demand for natural and organic products, as well as the increasing interest in alternative medicine and holistic approaches to healthcare. Local special circumstances have also played a role in the development of the Pharmacies market in Indonesia. The country's large population and rapid urbanization have created a significant demand for healthcare services, including pharmacies. The government's efforts to improve access to healthcare, particularly in rural areas, have also contributed to the growth of the Pharmacies market. Underlying macroeconomic factors have further supported the growth of the Pharmacies market in Indonesia. The country's strong economic growth and rising disposable incomes have increased the affordability of healthcare services for a larger segment of the population. Additionally, the government's focus on healthcare infrastructure development and the implementation of universal healthcare coverage have also boosted the demand for pharmacies in the country. In conclusion, the Pharmacies market in Indonesia is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The preference for easily accessible healthcare services, the adoption of digital technologies, the focus on holistic healthcare solutions, the country's large population and rapid urbanization, and the strong macroeconomic environment have all contributed to the growth of the Pharmacies market in Indonesia.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.